IL73885A - 2'-o-acetyl erythromycin stearate,its preparation and antibiotic compositions containing it - Google Patents

2'-o-acetyl erythromycin stearate,its preparation and antibiotic compositions containing it

Info

Publication number
IL73885A
IL73885A IL73885A IL7388584A IL73885A IL 73885 A IL73885 A IL 73885A IL 73885 A IL73885 A IL 73885A IL 7388584 A IL7388584 A IL 7388584A IL 73885 A IL73885 A IL 73885A
Authority
IL
Israel
Prior art keywords
preparation
compositions containing
antibiotic compositions
erythromycin stearate
acetyl erythromycin
Prior art date
Application number
IL73885A
Other languages
English (en)
Other versions
IL73885A0 (en
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of IL73885A0 publication Critical patent/IL73885A0/xx
Publication of IL73885A publication Critical patent/IL73885A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
IL73885A 1984-01-06 1984-12-20 2'-o-acetyl erythromycin stearate,its preparation and antibiotic compositions containing it IL73885A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (2)

Publication Number Publication Date
IL73885A0 IL73885A0 (en) 1985-03-31
IL73885A true IL73885A (en) 1988-10-31

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
IL73885A IL73885A (en) 1984-01-06 1984-12-20 2'-o-acetyl erythromycin stearate,its preparation and antibiotic compositions containing it

Country Status (38)

Country Link
US (1) US4599326A (sv)
JP (1) JPS60158197A (sv)
KR (1) KR900006237B1 (sv)
AT (1) AT386414B (sv)
AU (1) AU565688B2 (sv)
BE (1) BE901411A (sv)
BG (1) BG43189A3 (sv)
CA (1) CA1224461A (sv)
CH (1) CH666275A5 (sv)
CS (1) CS247191B2 (sv)
CY (1) CY1462A (sv)
DE (1) DE3500179A1 (sv)
DK (1) DK149776C (sv)
ES (1) ES8605818A1 (sv)
FI (1) FI77249C (sv)
FR (1) FR2557878B1 (sv)
GB (1) GB2152502B (sv)
HK (1) HK11590A (sv)
HU (1) HU196221B (sv)
IE (1) IE57967B1 (sv)
IL (1) IL73885A (sv)
IS (1) IS2968A7 (sv)
IT (1) IT1184304B (sv)
KE (1) KE3841A (sv)
LU (1) LU85721A1 (sv)
MA (1) MA20316A1 (sv)
MX (1) MX156277A (sv)
NL (1) NL8403979A (sv)
NO (1) NO160263C (sv)
NZ (1) NZ210606A (sv)
PH (1) PH22471A (sv)
PL (1) PL144349B1 (sv)
PT (1) PT79777B (sv)
RO (1) RO91262B (sv)
SE (1) SE461854B (sv)
SU (1) SU1410866A3 (sv)
YU (1) YU44485B (sv)
ZA (1) ZA8410143B (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP1594467A4 (en) * 2002-07-05 2008-10-22 Collegium Pharmaceutical Inc MISUSE OF PHARMACEUTICAL COMPOSITIONS OF OPIOIDES AND OTHER MEDICAMENTS
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
KR20060109922A (ko) * 2003-10-31 2006-10-23 알자 코포레이션 가바펜틴 및 프리가발린의 개선된 흡수를 위한 조성물 및제형
HUE037643T2 (hu) 2004-06-12 2018-09-28 Collegium Pharmaceutical Inc Visszaélésre nem alkalmas gyógyszerkészítmények
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
EP2158898A1 (en) 2006-06-23 2010-03-03 Aegis Therapeutics LLC Stabilizing alkylglycoside compositions and method thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP3566711A1 (en) 2011-05-18 2019-11-13 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
EP4047023A1 (en) 2012-11-20 2022-08-24 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
EP3653649A1 (en) 2012-11-20 2020-05-20 Mederis Diabetes, LLC Improved peptide pharmaceuticals for insulin resistance
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
IL285613B1 (en) 2014-05-28 2024-07-01 Mederis Diabetes Llc Improved peptide drugs for insulin resistance
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
MX2019013735A (es) 2017-05-19 2020-01-15 Lunella Biotech Inc Antimitoscinas: inhibidores especificos de la biogenesis mitocondrial para erradicar celulas madre cancerosas.
EP3717015A4 (en) 2017-12-01 2021-07-28 Lunella Biotech, Inc. REPURPOSCINS: TARGET MITOCHONDRIAL BIOGENESIS INHIBITORS TO ERADICATE CARCINOUS STEM CELLS
ES2935684T3 (es) 2018-02-06 2023-03-09 Aegis Therapeutics Llc Formulaciones de epinefrina intranasales y métodos para el tratamiento de enfermedades
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
CN113453690A (zh) * 2018-12-17 2021-09-28 卢内拉生物技术有限公司 用于抗衰老的三联疗法
US20220040316A1 (en) * 2018-12-17 2022-02-10 Lunella Biotech, Inc. Triple combination therapies for targeting mitochondria and killing cancer stem cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
NO850007L (no) 1985-07-08
DK149776C (da) 1987-04-21
ES8605818A1 (es) 1986-04-01
HUT37628A (en) 1986-01-23
NZ210606A (en) 1987-08-31
RO91262A (ro) 1987-06-30
SE461854B (sv) 1990-04-02
FR2557878A1 (fr) 1985-07-12
AU565688B2 (en) 1987-09-24
HK11590A (en) 1990-02-23
BG43189A3 (en) 1988-04-15
NL8403979A (nl) 1985-08-01
IL73885A0 (en) 1985-03-31
KR900006237B1 (ko) 1990-08-27
JPH029040B2 (sv) 1990-02-28
NO160263B (no) 1988-12-19
RO91262B (ro) 1987-07-01
IE57967B1 (en) 1993-06-02
IT8519012A0 (it) 1985-01-04
GB2152502B (en) 1987-10-07
JPS60158197A (ja) 1985-08-19
SU1410866A3 (ru) 1988-07-15
ZA8410143B (en) 1985-08-28
PH22471A (en) 1988-09-12
CH666275A5 (de) 1988-07-15
KE3841A (en) 1989-04-07
KR850005452A (ko) 1985-08-26
IT1184304B (it) 1987-10-28
DK149776B (da) 1986-09-29
FI850023L (fi) 1985-07-07
CA1224461A (en) 1987-07-21
DE3500179C2 (sv) 1989-08-24
YU2085A (en) 1987-12-31
ATA985A (de) 1988-01-15
GB2152502A (en) 1985-08-07
YU44485B (en) 1990-08-31
MA20316A1 (fr) 1985-10-01
AT386414B (de) 1988-08-25
ES539349A0 (es) 1986-04-01
DK5884D0 (da) 1984-01-06
AU3705984A (en) 1985-07-11
PL144349B1 (en) 1988-05-31
FI850023A0 (fi) 1985-01-03
FI77249C (sv) 1989-02-10
SE8406671D0 (sv) 1984-12-28
PT79777B (en) 1986-10-21
GB8432368D0 (en) 1985-02-06
SE8406671L (sv) 1985-07-07
US4599326A (en) 1986-07-08
LU85721A1 (fr) 1985-07-24
FI77249B (fi) 1988-10-31
DK5884A (da) 1985-07-07
DE3500179A1 (de) 1985-07-18
CS247191B2 (en) 1986-12-18
BE901411A (fr) 1985-04-16
HU196221B (en) 1988-10-28
CY1462A (en) 1989-07-21
PT79777A (en) 1985-01-01
IE850022L (en) 1985-07-06
IS2968A7 (is) 1985-04-03
NO160263C (no) 1989-03-29
MX156277A (es) 1988-08-04
FR2557878B1 (fr) 1988-01-15
PL251457A1 (en) 1985-11-05

Similar Documents

Publication Publication Date Title
IL73885A (en) 2'-o-acetyl erythromycin stearate,its preparation and antibiotic compositions containing it
IL76385A (en) S 541 macrolides and their preparation,and pharmaceutical and pesticidal compositions containing them
GR3001548T3 (en) Macrolide compounds, their preparation and their use
ZA892801B (en) Macrolide compositions
NZ211895A (en) 1,4-dihydro-4-oxonaphthyridine derivatives, and antibacterial compositions containing such
IL93914A0 (en) 4(3h)-pteridinones,their preparation and pharmaceutical compositions containing them
US4997924B1 (en) 5'-deoxy-4',-5'-unsaturated-5'-substituted adenosines
GB2192630B (en) Macrolide compounds
EG18720A (en) Macrolide compounds, their preparation and their use
IL86888A0 (en) 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives and pharmaceutical compositions containing them
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
IL94600A0 (en) Pyridobenzoindole compounds,their preparation and compositions containing them
GB2238540B (en) 13-deoxy-4'-deoxy-4'-iodoanthracyclines
GB2187742B (en) Macrolide compound
HK39295A (en) Macrolide compounds
GB9012743D0 (en) Antiparasitic macrolide compositions
GB8500263D0 (en) 4'-deoxy-4'-halodoxorubicin-14-esters
GB8809615D0 (en) 4-demethoxy-4'-deoxy-4'-iodo anthracy-cline glycosides
IE862753L (en) Compositions containing tylosin and a beta-lactam¹antibiotic.
ZA871759B (en) Macrolide compound
ZM6685A1 (en) Antibiotic compounds and their preparation
IE893701L (en) 2'-deoxy-4'-azido-substituted nucleosides
PH24384A (en) Aminoalkanoyl-dibenzo (d,g) (1,3,6) dioxazocines and composition thereof
CS738884A1 (en) Kmen mikroorganizmu streptomyces fradiae ccm 3765
GB8801423D0 (en) Water-soluble antibiotic composition

Legal Events

Date Code Title Description
RH Patent void